Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.00 | -22.08 |
| PEG Ratio (TTM) | N/A | 15.66 |
| P/S Ratio (TTM) | 0.01 | 49.38 |
| P/B Ratio (TTM) | 1.83 | 18.85 |
| P/FCF Ratio (TTM) | -0.18 | -3.07 |
| Price to 5YR AVG Earnings Ratio | N/A | -3.42 |
| Price to 5YR AVG FCF Ratio | N/A | -9.04 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -43,099.91% | -5.15% |
| ROE (TTM) | -39,095.64% | 16.37% |
| Net Profit Margin (TTM) | -391.01% | -2,030.32% |
| ROIC 5YR AVG | N/A | 15.65% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -19,243.05% | -921.41% | N/A |
| Revenue | 23,335.28% | -21.20% | N/A |
| Net Income | -19,656.80% | -921.19% | N/A |
| Cash Flow | -16.87% | -1,139.98% | N/A |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.33 | 6.19 |
| Quick Ratio (TTM) | 4.33 | 5.91 |
| D/E Ratio (TTM) | 0.05 | -15.10 |
| Interest Coverage (TTM) | 87.99 | -1.60 |
| Piotroski F-Score | 5 | 5 |
| Altman Z-Score | N/A | 14.02 |
| LTL to 5YR AVG FCF | N/A | 0.18 |
| Shares Outstanding Growth 5YR AVG | N/A | 123.85% |